Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma

SIMPLE SUMMARY: Despite success of targeted therapy, cancer cells very often find a way to survive treatment; this eventually causes a tumor to relapse. In a particular type of lymphoma carrying a specific chromosomal rearrangement named anaplastic large-cell lymphoma (ALCL), selective drugs targeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Arosio, Giulia, Sharma, Geeta G., Villa, Matteo, Mauri, Mario, Crespiatico, Ilaria, Fontana, Diletta, Manfroni, Chiara, Mastini, Cristina, Zappa, Marina, Magistroni, Vera, Ceccon, Monica, Redaelli, Sara, Massimino, Luca, Garbin, Anna, Lovisa, Federica, Mussolin, Lara, Piazza, Rocco, Gambacorti-Passerini, Carlo, Mologni, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431561/
https://www.ncbi.nlm.nih.gov/pubmed/34503232
http://dx.doi.org/10.3390/cancers13174422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431561/
https://www.ncbi.nlm.nih.gov/pubmed/34503232
http://dx.doi.org/10.3390/cancers13174422

Ejemplares similares